Lung Stent Market Expected to Reach USD 393.2 Million by 2032

The global lung stent market, estimated at USD 161.7 million in 2024, is poised for strong expansion, with a projected compound annual growth rate (CAGR) of 9.3% from 2025 to 2034. This significant growth is driven by several key factors, including the rising incidence of chronic respiratory conditions, rapid advancements in minimally invasive procedures, and increasing investments in innovative medical technologies. A growing number of people are being affected by respiratory ailments, largely due to factors such as air pollution, tobacco use, and inactive lifestyles. As a result, the demand for lung stents is on the rise, given their vital role in keeping airways open and improving respiration for patients with obstructions caused by tumors, infections, or congenital defects.

Lung stents are gaining widespread recognition for their ability to enhance patient outcomes by providing effective airway management solutions. The healthcare industry is gradually transitioning toward minimally invasive approaches that offer quicker patient recovery, fewer complications, and reduced costs. Technological innovations have led to the development of stents that can adapt to a wide range of airway anatomies. Moreover, the integration of artificial intelligence-powered imaging and navigation systems has significantly improved the accuracy of stent placement, contributing to better treatment results. The growing elderly population—more prone to respiratory diseases—further boosts demand. Additionally, government initiatives promoting advanced respiratory care, along with favorable reimbursement policies, are propelling the market forward.

The market is categorized into three primary product types: tracheal, bronchial, and laryngeal stents. Among these, tracheal stents held the largest share in 2024, accounting for USD 111.9 million. Their extensive use in treating severe airway obstructions has established them as the preferred choice among clinicians. These stents provide immediate relief in critical respiratory situations, ensuring proper airflow and minimizing the risk of complications. They are frequently employed in both urgent and scheduled procedures.

From a device type perspective, the market includes self-expandable and balloon-expandable stents. The self-expandable segment led with USD 126.5 million in 2024 and is forecasted to grow at a CAGR of 9.4% through 2034. Their popularity stems from their simple deployment and ability to conform to intricate airway anatomies. Once in place, these stents automatically expand, reducing the duration of procedures and enhancing placement accuracy. Their dependability and performance make them particularly beneficial in emergency settings that demand swift airway restoration.

In the United States, the lung stent market reached USD 63.6 million in 2024 and is projected to expand at a CAGR of 8.8% over the next decade. The U.S. continues to lead globally due to its sophisticated healthcare infrastructure, high prevalence of pulmonary conditions, and growing emphasis on minimally invasive solutions. The adoption of advanced technologies—such as AI-assisted imaging—is improving placement precision and reinforcing the country's dominant position. Government support and well-structured reimbursement systems further contribute to the steady market growth in the region.

Source: https://www.gminsights.com/industry-analysis/lung-stent-market